Sitemap > Breaking Research > Diagnostics & Devices
Displaying 951 - 1000 of 1058 results
- Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study.
- The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy.
- Bevacizumab Reduces the Growth Rate Constants of Renal Carcinomas: A Novel Algorithm Suggests Early Discontinuation of Bevacizumab Resulted in a Lack of Survival Advantage.
- Multifocal, Persistent Cardiac Uptake of [18-F]-Fluoro-Deoxy-Glucose Detected by Positron Emission Tomography in Patients With Acute Myocardial Infarction.
- An alternative method for screening EGFR mutation using RFLP in non-small cell lung cancer patients.
- Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancer.
- Prognostic value of the PAI-1 4G/5G polymorphism in invasive ductal carcinoma of the breast.
- hLH/hCG-receptor expression correlates with in vitro invasiveness in human primary endometrial cancer.
- Cost per day of patency: Understanding the impact of patency and reintervention in a sustainable model of healthcare.
- Ultra-sensitive immunosensor for beta-amyloid (1-42) using scanning tunneling microscopy-based electrical detection.
- Multimodality imaging of IL-18--binding protein-Fc therapy of experimental lung metastasis.
- Salivary proteomics for oral cancer biomarker discovery.
- Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer.
- Fluorescence in situ hybridization subgroup analysis of TRIBUTE, a phase III trial of erlotinib plus carboplatin and paclitaxel in non-small cell lung cancer.
- A high-throughput RNA interference screen for DNA repair determinants of PARP inhibitor sensitivity.
- Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: The Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial.
- Combined (18)F-FDG-PET/CT Imaging in Radiotherapy Target Delineation for Head-and-Neck Cancer.
- [(18)F]-labeled isoindol-1-one and isoindol-1,3-dione derivatives as potential PET imaging agents for detection of beta-amyloid fibrils.
- High Sensitivity: High-Resolution SPECT-CT/MR Molecular Imaging of Angiogenesis in the Vx2 Model.
- Dethrombosis of the Lower Extremity Arteries Using the Power-Pulse Spray Technique in Patients with Recent Onset Thrombotic Occlusions: Results of the DETHROMBOSIS Registry.
- Expression of carbonic anhydrase 9, a potential intrinsic marker of hypoxia, is associated with poor prognosis in oesophageal squamous cell carcinoma.
- Activated Akt as an indicator of prognosis in gastric cancer.
- Design and Synthesis of Highly Sensitive Fluorogenic Substrates for Glutathione S-Transferase and Application for Activity Imaging in Living Cells.
- The performance of human papillomavirus high-risk DNA testing in the screening and diagnostic settings.
- Diagnostic value of FDG-PET in recurrent colorectal carcinoma: A meta-analysis.
- HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study.
- Differentiation of tumor recurrence from radiation necrosis in high-grade gliomas using (201)Tl-SPECT.
- Breast tumor targeting with (99m)Tc-HYNIC-PR81 complex as a new biologic radiopharmaceutical.
- Synthesis and evaluation of novel radioiodinated nicotinamides for malignant melanoma.
- Labelling and biological evaluation of [(11)C]methoxy-Sch225336: a radioligand for the cannabinoid-type 2 receptor.
- Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging.
- Use of a novel anti-proliferative compound coated on a biopolymer to mitigate platelet-derived growth factor-induced proliferation in human aortic smooth muscle cells: comparison with sirolimus.
- Lower recurrence risk through mammographic screening reduces breast cancer treatment costs.
- Carbon nanotube based biomedical agents for heating, temperature sensoring and drug delivery.
- Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography.
- Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies.
- Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers.
- Chemosensitivity and Stratification by a Five Monoclonal Antibody Immunohistochemistry Test in the NSABP B14 and B20 Trials.
- First Demonstration of Leukemia Imaging with the Proliferation Marker 18F-Fluorodeoxythymidine.
- Fluorescence Reflectance Imaging of Macrophage-Rich Atherosclerotic Plaques Using an {alpha}v{beta}3 Integrin-Targeted Fluorochrome.
- Optimal Detection of Sentinel Lymph Node Metastases by Intraoperative Radioactive Threshold and Molecular Analysis in Patients with Melanoma.
- Preparation and Biological Evaluation of 64Cu-CB-TE2A-sst2-ANT, a Somatostatin Antagonist for PET Imaging of Somatostatin Receptor-Positive Tumors.
- In Vitro and In Vivo Evaluations of a Hydrophilic 64Cu-Bis(Thiosemicarbazonato)-Glucose Conjugate for Hypoxia Imaging.
- Effect of Prolonged Thienopyridine Use After Drug-Eluting Stent Implantation (from the TAXUS Landmark Trials Data).
- One-Step Label-Free Optical Genosensing System for Sequence-Specific DNA Related to the Human Immunodeficiency Virus Based on the Measurements of Light Scattering Signals of Gold Nanorods.
- CXCL16 is a surrogate marker of inflammatory bowel disease.
- Identification of candidate molecular markers of nasopharyngeal carcinoma by microarray analysis of subtracted cDNA libraries constructed by suppression subtractive hybridization.
- Tissue plasminogen activator (tPA) activity is a novel and early marker of asymptomatic LEAD in type 2 diabetes.
- Genotypic Antiretroviral Resistance Testing for Human Immunodeficiency Virus Type 1 Integrase Inhibitors on the TruGeneTM Sequencing System.
- Evaluation of the LIAISON(R) Borrelia burgdorferi Test, a Recombinant VlsE-based Chemiluminescence Immunoassay for the Diagnosis of Lyme Disease.